Q² Solutions Expands Bioanalytical Capabilities in China

Morrisville, N.C. – July 11, 2018 – Q2 Solutions, a global clinical trials laboratory services organization, announced today the expansion of its bioanalytical capabilities in Beijing, China. This expansion includes standardization across our global bioanalytical laboratories in support of regulatory success throughout the drug development continuum.

“Our bioanalytical capabilities expansion in China is an important part of our strategic plan aimed at supporting the needs of the China market and the global drug development needs of our customers around the world,” said Kevin Jones, Q2 Solutions Vice President and General Manager of Bioanalytical and ADME Laboratories.

The bioanalytical operation conducted at the Q2 Solutions Beijing facility is GLP compliant (CFDA and US FDA), delivering reliability and reproducibility to support global clinical pharmacokinetic studies and exploratory biomarker analysis. The facility also includes Q2 Solutions’ Central Laboratory, which is College of American Pathologists (CAP) accredited and was the first lab in China with CAP ISO 15189 certification. This co-located lab helps simplify sample management and reduce transportation costs.

New bioanalytical services include ligand binding based large molecule bioanalysis to supplement existing small molecule liquid chromatography/mass spectrometry (LC/MS) services. Our bilingual team of experts provide dedicated project management, esoteric testing, high-quality data, analytics, sample management, and logistics.

Contact us to learn more about our full set of laboratory services in China, which support a broad spectrum of development needs, with delivery excellence to help ensure high-quality data is generated for regulatory approval in China and throughout the world.

About Q2 Solutions

Launched in 2015, Q2 Solutions is a leading global clinical trials laboratory services organization. We help biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q2 Solutions is a quality driven, responsive partner with strong global experience and deep scientific and medical expertise. The Q2 Solutions joint venture was formed by Quintiles and Quest Diagnostics, combining the best of each parent organizations clinical trials laboratory services capabilities. To learn more, visit